Scientist 2/Senior Scientist
Magnet Biomedicine
Scientist 2/Senior Scientist
Magnet Biomedicine
Develops small-molecule molecular glue therapeutics
Magnet is a biotechnology company pioneering the discovery of oral molecular glues - small molecules that induce proximity between proteins to modulate their function. Our proprietary TrueGlue(TM) platform is designed to address hard-to-drug targets across cancer and immune-mediated diseases.
With support from ARCH Venture Partners, Newpath Partners, Taiho Ventures, and Eli Lilly, Magnet is advancing internal programs in oncology, immunology, and inflammation. Magnet has also entered into a collaboration and license agreement with Eli Lilly to discover, develop, and commercialize specific molecular glue therapeutics in oncology.
Position Summary
We are seeking a highly motivated and hands-on biologist to join our team. In this position, you will play a pivotal role in designing, executing, and interpreting experiments to develop novel protein-protein interaction strategies that modulate target protein function. This is a unique opportunity to contribute to the development of next-generation therapeutics and make a significant impact on the biotechnology and pharmaceutical industries.
The successful candidate will conduct phenotypic cell-based assays, enzymatic assays, and binding experiments while collaborating closely with a multidisciplinary team of scientists to discover and develop molecular glue therapeutics. The ideal candidate is scientifically curious, highly collaborative, and motivated to continuously expand their technical expertise while contributing to a fast-paced research environment.
Key Responsibilities
Required Qualifications and Skills
Preferred Qualifications
National salary range. Salary will be determined by many factors, including but not limited to, specific competencies, relevant education, qualifications, certifications, experience, skills, performance, location and business or organizational needs. 130000 - 170000 USD
Develops small-molecule molecular glue therapeutics
Magnet Biomedicine builds small-molecule therapeutics called molecular glues that modulate protein–protein interactions to address targets that are hard to drug. Its TrueGlue platform uses proprietary chemical libraries and human biology to select targets and design glues that recruit a presenter protein to a disease-relevant target, altering function or stability rather than simply degrading it. The company differentiates itself by aiming for tissue-specific effects and a broader range of outcomes beyond degradation, backed by chemistry-driven discovery and strong industry partnerships. Its goal is to bring novel medicines to patients, focusing on oncology, cardiovascular disease, and immune disorders, with collaborations like the Lilly deal to accelerate development and commercialization.
Explore more opportunities at Magnet Biomedicine